Significance of the Study

Report 4 Downloads 165 Views
2015 한국경영정보학회 추계통합학술대회

The Determinants of National Biotechnology Innovation Capacity

이상원 (경희대학교 언론정보학과)

(경희대 언론정보학과) 이상원 (경희대 언론정보학과) 김도한 (경희대학교 행정학과)

1

Significance of the Study  Innovation in biotechnology has become a key component

of the knowledge economy and national competitiveness.  Well-established information and communications

technology (ICT) infrastructure such as broadband and R&D expenditure are necessary to promote national-level innovation in biotechnology.  Employing panel data from 33 OECD countries, this study

investigates drivers of national biotechnology innovation capacity (Macro-level approach)

Drivers of technological innovation in Biotech Industry !!!

-533-

2

2015 한국경영정보학회 추계통합학술대회

Purpose of the Study This study examines  The effects of macro-level drivers of technological innovation in biotech industry:  Broadband Diffusion  R& D expenditure  R&D expenditure by government  Education  Income

3

The Status of Biotechnology Innovation, Broadband Infrastructure, R&D expenditure 2.5

80

70 2 60

50

1.5

40 1

30

20 0.5 10

0

0 1999

2000

2001 2002 2003 2004 cumulative biotechnology

2005 2006 2007 2008 2009 cumulative fixed broadband

2010 2011 2012 R&D expenditures

2013

 The biotechnology patent statistics show that while there has been a steady growth in worldwide biotechnology innovation capacity, a wide range of biotechnology innovation levels exists across countries.

-534-

4

2015 한국경영정보학회 추계통합학술대회

The Empirical Model  A country fixed effect model for the estimation  This study employs a fixed effect model, which controls for the unobserved heterogeneity among countries. LnBit = β0it + β1it*lnFixedBroadband + β2it*RD + β3it*RD_GOV + β4it*(RD_GOV)2 + β5it*EDU + β6it*INC + δiZi + εit

 LnBit: Biotech Innovation in country i in time t

 β0it : Constant  Zit : Country-dummies  εit : Error Term 5

The Model, Method, and Data Variables Biotechnology innovation Fixed broadband

Measurement Cumulative patents grants in biotechnology per 1,000,000

Data sources OECD

inhabitants between 1999-2013 Fixed-broadband subscribers per 100 inhabitants

ITU

penetration R&D expenditure

Research and development expenditure (percent of GDP)

World Bank

R&D financed by

R&D financed by government (percentage of total R&D financed)

World Bank

Education

School enrollment, secondary (percent of GDP)

World Bank

Income

GDP per capita

World Bank

government

 

Data Sources: Yearly Data (1999-2013) from OECD, World Bank, ITU, Data for 33 countries 6

-535-

2015 한국경영정보학회 추계통합학술대회

Empirical Results: Fixed effect OLS model (1)

(2)

(3)

(4)

0.190*** (0.051)

0.040** (0.017) 0.160*** (0.051)

0.006*** (0.002) 0.000*** (0.000) -0.958*** (0.322)

0.005*** (0.002) 0.000 (0.000) -0.710** (0.301)

0.005*** (0.002) 0.000** (0.000) -0.944*** (0.318)

0.030* (0.017) 0.118** (0.052) 0.046*** (0.013) -0.001*** (0.000) 0.006*** (0.002) 0.000*** (0.000) -1.853*** (0.424)

473 0.931 33

492 0.933 33

473 0.933 33

473 0.937 33

VARIABLES Fixed broadband penetration

0.034** (0.017)

R&D expenditure R&D government financed (R&D government financed)2 Education Income Constant

Observations R-squared Number of country

* Statistically significant at the 10% level ** Statistically significant at the 5% level ***Statistically significant at the 1% level

Empirical Results: Fixed effect OLS model (Broadband lagged variable) (1) VARIABLES Fixed broadband penetration (lagged variable) R&D expenditure R&D government financed (R&D government financed)2 Education Income Constant Observations R-squared Number of country

(2)

(3)

Two-year lagged

Three-year lagged

0.029*

0.026*

0.039***

(0.015) 0.105** (0.048) 0.033** (0.013) -0.000*** (0.000) 0.005*** (0.002) 0.000*** 0.029* 0.845** (0.421) 441 0.931 33

(0.014) 0.100** (0.045) 0.020 (0.012) -0.000** (0.000) 0.005*** (0.001) 0.000*** (0.000) -0.274 (0.383) 408 0.925 33

(0.014) 0.114** (0.045) 0.012 (0.013) -0.000 (0.000) 0.004*** (0.002) 0.000*** (0.000) 1.427*** (0.432) 375 0.914 33

One-year lagged

* Statistically significant at the 10% level ** Statistically significant at the 5% level ***Statistically significant at the 1% level

-536-

2015 한국경영정보학회 추계통합학술대회

cumulative number of patents in biotechnology 0 50 100 150

Fixed broadband penetrations and cumulative number of patents in biotechnology between 1999 and 2013 scatterplot by countries between 1999-2013 Denmark United States

Israel Switzerland Sweden Canada Belgium Australia New Zealand Austria

Iceland

Netherlands

Finland United Kingdom Japan Germany France Norway

Ireland Italy Slovenia Hungary SpainEstonia Slovak Czech Republic Republic Greece Portugal Chile Poland Mexico Turkey

5

Korea, Rep.

10 15 20 cumulative number of fixed broadband penetration

25

Government financed R&D and cumulative number of patents in biotechnology between 1999 and 2013 cumulative number of patents in biotechnology 0 50 100 150

scatterplot by countries between 1999-2013 Denmark United States

Israel Switzerland Sweden Canada Belgium Finland Japan

Iceland Netherlands United Kingdom Germany Australia Austria France

New Zealand Norway

Ireland Korea, Rep.

10

20

Slovenia Chile

30 40 government finance

-537-

Italy Estonia Spain Czech Hungary Republic Slovak Republic Greece Portugal MexicoPoland Turkey

50

60

2015 한국경영정보학회 추계통합학술대회

Discussion  The results of the data analysis indicate that fixed

broadband diffusion is one of the main drivers of biotechnology innovation.  The effect of fixed broadband diffusion on

biotechnology innovation lasted at least three years, controlling for other factors.  This finding implies that broadband infrastructure

has a long-term impact on biotechnology innovation in many countries. 11

Discussion  This study also found that R&D expenditure has an

impact on biotechnology innovation.  R&D for biotechnology also plays a leading role in

building the knowledge-based innovation system in the biotechnology field.  This result also suggests that the creation and

management of marketable knowledge capital by R&D investment is necessary for stimulating biotechnology innovation. 12

-538-

2015 한국경영정보학회 추계통합학술대회

Discussion  The study found that there is an inverse U-shaped

relationship between R&D government financed and biotechnology innovation.

 It appears that diversity of R&D financed ((e.g.) R&D

financed industry and R&D financed by university) is necessary for biotechnology innovation.

13

Discussion  The results of the data analysis also indicate that

education is a statistically significant factor in explaining biotechnology innovation.

 This finding implies that maintaining higher

education and research is critical to biotechnology innovation in many countries.

14

-539-

2015 한국경영정보학회 추계통합학술대회

Limitations & Future Studies  Because of data availability, additional

independent variables could not be included in the fixed-effects regression model.  Further studies may include more diverse

independent variables in the empirical model, such as regulatory policy factors in the biotechnology and health sectors.  Future research may also address whether

intellectual property rights protection in a country affects biotechnology innovation. 15

Questions

16

-540-